Little Journey secures £6m Series A funding round with backing from Foresight Group and other investors.
Little Journey develops digital health solutions designed to support children and their caregivers through medical procedures and clinical trials. The company provides a cloud-based mobile platform used across NHS hospitals and life sciences organisations.
Little Journey has completed a £6m Series A funding round, bolstered by a £300k investment from Foresight Group alongside backing from Mercia, Octopus Ventures, and Par Equity. The capital will be directed towards commercial expansion, product development, and strengthening marketing activities. This latest injection of funds follows the company's growth within NHS hospitals and its expansion into the global paediatric clinical trials sector.
From the founder
"We are delighted to have secured this investment from Foresight, which will accelerate Little Journey’s product development and commercial expansion. We look forward to working with the Foresight team to continue to deliver our mission of supporting all children to better health through personalised care."
Chris Evans
Co-Founder and CEO at Little Journey
Investor perspective
"Little Journey is delivering meaningful improvements in paediatric healthcare and clinical trials through its award-winning, innovative technology. With strong roots in the UK and growing global demand, we are delighted to be supporting the Little Journey team as they enter their next phase of growth."
Louise Mackie
Investment Manager, Foresight
Use of funds
- 01Expand into international markets
- 02Continue product development
- 03Invest in sales and marketing
Investors
Categories
About the company
Little Journey
Digital health platform supporting children and families through medical procedures and clinical trials.